Bohndiek Group to Race for Life

Professor Sarah Bohndiek, joined by lab members Tom Else, Katie-Lou White, Kris Dreher and Janek Gröhl, will be racing alongside Cancer Research UK supporters at this year’s Race for Life 10k at Jesus Green on Sunday 2 July.
This is the 30th year of Race for Life and the fifth time that Prof Bohndiek has taken part. She hopes her work in Cambridge – developing cutting-edge imaging to detect and monitor cancer – and her dedication to Race for Life – in memory of her nan and aunt, who both died of breast cancer – will help inspire people to keep raising funds.
Prof Sarah Bohndiek, Cancer Research UK Cambridge Institute said: “Race for Life is an inspiring day. It’s an event where everyone’s got this common experience – you’re there for a person you love who’s been affected by cancer and has either survived or isn’t with you anymore, and you’re cherishing that person and celebrating their life, so it’s quite emotional, but at the same time it’s really inspiring because everybody’s there coming together to try and beat the disease.
“I’m really lucky to have a lot of support from Cancer Research UK. Being part of the CRUK Cambridge Institute means the process of testing new hypotheses and ideas is quick, meaning we can try out risky ideas, but have the flexibility to move on to something new if things don’t work out. Outside of an institute, without the core funding, facilities and infrastructure we have here, it’s a much longer process.
“We can also build from the knowledge base other people have here, so even if my team want to do an experiment none of us have experience in, there’s always somebody in the institute who knows how to do it and, because everyone’s so collaborative, they can help us get off the ground.
“The fact money raised at Race for Life goes to support this broad infrastructure for research, allowing non-specialists to try out new experiments and do different things, really accelerates the process of research.”
Every year around 38,400 people are diagnosed with cancer in the East of England and one in two people in the UK born after 1960 will get cancer in their lifetime. Money raised at Race for Life enables scientists to find new ways to prevent, diagnose and treat cancer – helping to save more lives.
Michael Jarvis, Cancer Research UK’s spokesperson in the East of England, said: “We’re really grateful to Prof Bohndiek, her lab and everyone else who’s taken part and supported Race for Life alongside Prof Bohndiek over the years.
“Sadly, cancer affects all of us in some way. We’ve seen survival rates in the UK double in the last 40 years thanks to the tireless efforts of researchers. Science is winning, but this can only happen with the continued support of fundraisers up and down the country.
“Whether people are living with cancer, taking part in honour of or in memory of a loved one with cancer, or signing up to protect their own children’s future, everyone has a reason to Race for Life. We want to make sure everyone can join the Race for Life movement. Our participants come from different backgrounds, with different stories, but with one thing in common – the determination to help beat cancer.
“Together, we can bring about a future free from the fear of cancer. So, we’re asking people across Cambridgeshire: Who will you Race for?”
Cancer Research UK’s Race for Life raises funds for world-class research to help beat 200 types of cancer – including bowel cancer, breast cancer, prostate cancer, lung cancer, testicular cancer, brain cancer, children’s cancers and leukaemia.
Those interested can still enter by visiting: raceforlife.org
Related News
See all news-
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
10th March 2025
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more -
Richard Mair joins Institute as an Independent Clinical Fellow
10th February 2025
Richard will build a research group at the Institute to focus on IDH mutant astrocytoma, , a common type of brain tumour that accounts for 9% of brain tumour diagnoses.
Find out more -
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more